Benicar

Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
Reuters
Wed, 08/2/17 - 09:40 am
Daiichi Sankyo
Benicar
Daiichi's new clot-fighter Savaysa can't make up for $2.6B Benicar patent loss: analysts
Fierce Biotech
Mon, 02/9/15 - 06:06 pm
Daiichi Sankyo
Savaysa
Benicar
patents
FDA Ends Olmesartan Safety Review, But...
Forbes
Wed, 06/25/14 - 07:45 am
FDA
Olmesartan
Benicar
diabetes
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Xyrem
Jazz Pharmaceuticals
Humulin
Eli Lilly
Premarin
Mylan
Lunesta
Sunovion
Benicar
Daiichi Sankyo
Lantus
Sanofi
Viagra
Pfizer
Gleevec
Novartis
Copaxone
Teva Pharmaceuticals
EpiPen
drug pricing
Blood Pressure Drug Olmesartan Linked to Celiac Disease Side Effects in a Handful of Patients
ABC News
Fri, 06/22/12 - 09:31 am
celiac disease
Olmesartan
Benicar
Forest Labs says US Attorneys seek documents related to blood pressure drugs Benicar and Azor
Yahoo/AP
Wed, 05/11/11 - 10:30 am
Forest Labs
subpoena
Azor
Benicar
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Fri, 07/16/10 - 09:26 am
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
Common Blood Pressure Pills Linked To Cancer
Forbes
Mon, 06/14/10 - 12:15 pm
cancer
ARBs
Benicar
Daiichi Sankyo
Micardis
Boehringer Ingelheim
Merck
Cozaar
Novartis
Diovan
Takeda blood pressure drug tops rivals in studies
Reuters
Mon, 05/3/10 - 01:19 pm
antihypertensives
Takeda
azilsartan
Diovan
Benicar